News of Bahrain
Business9 July 20201 min read

Johnson & Johnson's Cilag to sell up to 11.8 million Idorsia shares

Zurich Johnson & Johnson's Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd in an accelerated bookbuilding to commence on Wednesday, the transaction's bookrunner said, according to Reuters. The sale corresponds to approximately 8.3

Editorial Team Legacy

Published 9 July 2020, 8:00 · Updated 21:28

Link copied
Johnson & Johnson's Cilag to sell up to 11.8 million Idorsia shares

Zurich

Johnson & Johnson’s Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd in an accelerated bookbuilding to commence on Wednesday, the transaction’s bookrunner said, according to Reuters. The sale corresponds to approximately 8.3% of Swiss drugmaker Idorsia’s outstanding ordinary share capital. Goldman Sachs will act as sole bookruner on the sale.

Join the conversation

Sign in to leave a comment. Every comment is reviewed before it goes live.

No comments yet. Start the conversation.